Are patients with primary glomerular disease at increased risk of malignancy?

被引:2
|
作者
Han, Jialin [1 ]
Zhao, Yinshan [2 ]
Canney, Mark [3 ,4 ]
Atiquzzaman, Mohammad [1 ]
Keown, Paul [1 ]
Levin, Adeera [1 ,5 ]
Barbour, Sean [1 ,5 ]
机构
[1] Univ British Columbia, Dept Med, Div Nephrol, Vancouver, BC, Canada
[2] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
[3] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[4] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Prov Hlth Serv Author, BC Renal, Vancouver, BC, Canada
关键词
cancer; ESRD; glomerulonephritis; immunosuppression; kidney transplantation; CANCER INCIDENCE; SYSTEMIC-LUPUS; RHEUMATOID-ARTHRITIS; LYMPHOMA RISK; SKIN-CANCER; ASSOCIATION; THERAPY; METAANALYSIS; EXPOSURE; GLOMERULONEPHRITIS;
D O I
10.1093/ndt/gfad261
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Over the past decade, several observational studies and case series have provided evidence suggesting a connection between glomerular diseases and the development of malignancies, with an estimated risk ranging from 5 to 11%. These malignancies include solid organ tumours as well as haematologic malignancies such as lymphoma and leukaemia. However, these risk estimates are subject to several sources of bias, including unmeasured confounding from inadequate exploration of risk factors, inclusion of glomerular disease cases that were potentially secondary to an underlying malignancy, misclassification of glomerular disease type and ascertainment bias arising from an increased likelihood of physician encounters compared with the general population. Consequently, population-based studies that accurately evaluate the cancer risk in glomerular disease populations are lacking. While it is speculated that long-term use of immunosuppressive medications and glomerular disease activity measured by proteinuria and estimated glomerular filtration rate may be associated with cancer risk in patients with glomerular disease, the independent role of these risk factors remains largely unknown. The presence of these knowledge gaps could lead to a lack of awareness of cancer as a potential chronic complication of glomerular disease, underutilization of routine screening practices in clinical care that allow early diagnosis and treatment of malignancies and underrecognition of modifiable risk factors to decrease the risk of de novo malignancies over time. This review summarizes the current evidence on the risk of cancer in patients with glomerular diseases, explores the limitations of prior studies and discusses methodological challenges and potential solutions for obtaining accurate estimates of cancer risk and identifying modifiable risk factors unique to GN populations. 10.1093/ndt/gfad261 Video Watch the video of this contribution at https://academic.oup.com/ndt/pages/author_videos gfad261Media1 6344835995112
引用
收藏
页码:910 / 919
页数:10
相关论文
共 50 条
  • [41] Increased Risk of Suicide among Cancer Survivors Who Developed a Second Primary Malignancy
    Yang, Huazhen
    Wang, Chengshi
    Lu, Donghao
    Song, Huan
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 258 - 258
  • [42] Risk of second primary malignancy in patients with primary myelofibrosis: A SEER database study.
    Joshi, Utsav
    Bhattarai, Adheesh
    Gaire, Suman
    Gill, Simrat
    Agrawal, Vishakha
    Bhetuwal, Uttam
    Kouides, Peter
    Bhatt, Vijaya Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [43] Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma
    Jin, Liyan
    Su, Xinyue
    Li, Wenjing
    Wu, Jie
    Zhang, Hua
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [44] Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide
    Merli, Michele
    Maffioli, Margherita
    Ferrario, Andrea
    Passamonti, Francesco
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (08) : 719 - 720
  • [45] Risk and outcome of second primary malignancy in patients with classical Hodgkin lymphoma
    Wang, Fan
    MEDICINE, 2022, 101 (48) : E31967
  • [46] Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone
    Chiou, Wen-Yen
    Chen, Chien-An
    Lee, Moon-Sing
    Lin, Hon-Yi
    Li, Chung-Yi
    Su, Yu-Chieh
    Tsai, Shiang-Jiun
    Hung, Shih-Kai
    MEDICINE, 2016, 95 (47)
  • [47] Increased risk of cancer in patients with primary sclerosing cholangitis
    Aiva Lundberg Båve
    Annika Bergquist
    Matteo Bottai
    Anna Warnqvist
    Erik von Seth
    Caroline Nordenvall
    Hepatology International, 2021, 15 : 1174 - 1182
  • [48] Increased risk of cancer in patients with primary sclerosing cholangitis
    Bave, Aiva Lundberg
    Bergquist, Annika
    Bottai, Matteo
    Warnqvist, Anna
    von Seth, Erik
    Nordenvall, Caroline
    HEPATOLOGY INTERNATIONAL, 2021, 15 (05) : 1174 - 1182
  • [49] Increased risk of osteoporosis in patients with primary biliary cirrhosis
    Liao, Chen-Yi
    Chung, Chi-Hsiang
    Chu, Pauling
    Wei, Kuang-yu
    Feng, Tseng-Min
    Lin, Fu-Huang
    Tsao, Chang-Huei
    Wu, Chia-Chao
    Chien, Wu-Chien
    PLOS ONE, 2018, 13 (03):
  • [50] Increased Risk of Post-Transplant Malignancy After Isolated Heart Transplant in Adult Patients with Congenital Heart Disease
    Leiva, Orly
    Golob, Stephanie
    Reyentovich, Alex
    Alvarez-Cardona, Jose
    Bloom, Michelle
    Halpern, Dan
    Small, Adam
    CIRCULATION, 2024, 150